Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives.
Nearly one-third of American consumers report experiencing a steep increase over the last year in prices paid for drugs they routinely take, which is having a spillover effect on all phases of their lives, from retirement planning to how much they can spend on groceries, according to a report from Consumer Reports.
The report is based on a survey of a nationally representative sample of consumers as well as a survey asking physicians how they address the issue of medication affordability. Survey respondents reported that had to make tradeoffs between paying for the medications they needed and necessities such as groceries and health care. Health insurance plans with very high deductibles forced many to shop around for lower prices and not use their insurance, said Lisa Gill, deputy editor of Consumer Reports Best Buy Drugs.
“Consumers aren’t used to questioning prices for pharmaceutical drugs—nor are they used to shopping around and haggling—but they could save themselves a lot of money if they do,” Gill said in a statement.
The new report found that consumers who experienced higher drug prices in the last 12 months were more likely to economize with their health in potentially dangerous ways. The following statistics compare all survey respondents taking a prescription drug with those who experienced a price increase: not complying with prescription medications to save money (33% vs 47%), putting off doctors’ visits because of cost (18% vs 28%), declining a medical test or procedure because of cost (14% vs 23%), and not filling a prescription because of cost (17% vs 30%), taking an expired medication (12% vs 19%), or not taking a scheduled dosage or prescribed medication to save money (10% vs 17%).
The survey also found that in the past year, consumers who took prescription medications took the following steps in order to pay for their prescription medications: spent less on entertainment and dining out (24% of all respondents vs 38% of those experiencing a price increase), got an insurance policy that covered medications (20% vs 24%), spent less on groceries (17% vs 31%), used credit cards more often (15% vs 25%), spend less on family (14% vs 25%), postponed paying other bills (11% vs 19%), postponed retirement to maintain health insurance coverage (6% vs 10%), and took a second job(4% vs 7%).
Consumer Reports identified 5 key reasons for the rise in drug prices profiled in their report:
Finally, the survey found that despite the burdens created by higher drug prices, only one-fourth of consumers surveyed said they discussed drug costs with their practitioners. Of those who did have such a discussion, 64% said they initiated it--a finding corroborated by the results of Consumer Report’s survey of internal medicine physicians. The physicians said in a typical week they discuss drug costs with only 2.6 of 10 patients, even though 80% of the physicians said they were concerned about their patients’ ability to pay for their treatments.
Evolving Roles of Antibody-Drug Conjugates in the Treatment of NSCLC
September 7th 2025Antibody-drug conjugates are rapidly reshaping the treatment landscape of non–small cell lung cancer (NSCLC), with advances in design, clinical efficacy, and regulatory approvals tempered by ongoing challenges in toxicity, resistance, and biomarker optimization.
Read More
AI in Health Care: Balancing Governance, Innovation, and Trust
September 2nd 2025In this conversation with Reuben Daniel, associate vice president of artificial intelligence at UPMC Health Plan, we dive into how UPMC Health Plan builds trust with providers and members, discuss challenges of scaling AI effectively, and hear about concrete examples of AI's positive impact.
Listen
Comparing Global Standards in Lung Cancer: NCCN, ESMO, and CHEST Guidelines
September 6th 2025National Comprehensive Cancer Network (NCCN), the European Society for Medical Oncology (ESMO), and the American College of Chest Physicians (CHEST) offer complementary yet distinct frameworks for lung cancer care, reflecting differences in evidence evaluation, regional adaptation, and policy integration.
Read More
Infertility Coverage Boosts ART Use and Pregnancy Success: Richard A. Brook, MS, MBA
August 26th 2025In this episode, Richard A. Brook, MS, MBA, discusses his study showing that infertility treatment coverage increases assisted reproductive technology (ART) use and improves pregnancy outcomes.
Listen